Summary: The American Journal of Managed Care brings attention to the increase in widespread mental health challenges during the COVID-19 pandemic and highlights the possible role of psychedelic-assisted therapy in achieving mass mental health.
Ismail L. Ali, J.D., Acting Director of Policy and Advocacy at MAPS, provides context-rich and policy-focused perspective concerning the implementation of psychedelics into mainstream medicine and culture.
“In my opinion, there’s multiple tracks,” says Ali. “We should be pushing for decriminalization; there should be a system of legal regulated adult use. Then, there also should be medical use and we just need to be mindful of which expectations are being played for which [track].”
Originally appearing here.